GlassScriptPhysician profile
Allison A Oliver
NPI 1942052972
$1,106.36
in general payments reported to CMS, 2019-2025
14 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $902 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,011 · Education: $94.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,011.41 |
| Education | $94.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $278.53 | 2024-2025 | Fasenra, Bevespi Aerosphere, Tezspire |
| Csl Behring | $181.06 | 2024-2025 | Hizentra, Haegarda |
| Genentech USA, INC. | $138.40 | 2024 | Xolair |
| Sanofi-Aventis U.S. LLC | $94.95 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $94.37 | 2024 | Dupixent |
| Pharming Healthcare, INC. | $90.18 | 2024-2025 | Ruconest |
| Takeda Pharmaceuticals U.S.A., INC. | $76.39 | 2024 | Hyqvia |
| Optinose US, INC. | $41.74 | 2024-2025 | |
| Greer Laboratories, INC. | $22.99 | 2025 | Oralair |
| Ars Pharmaceuticals Operations, INC. | $22.91 | 2025 | Neffy |
| Genzyme Corporation | $22.60 | 2024 | |
| Organon LLC | $14.54 | 2025 | Vtama |
| Biocryst US Sales Co., LLC | $14.41 | 2024 | Orladeyo |
| Cycle Pharmaceuticals INC | $13.29 | 2024 | Sajazir |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Oliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.